PDL1 in Alberta

User Tools

Site Tools

Trace: • keynote001
keynote001

The 2015 KEYNOTE-001 clinical trial for the Treatment of NSCLC using Pembrolizumab

https://www.nejm.org/doi/full/10.1056/nejmoa1501824

The 2015 KEYNOTE-001 Adverse Effects

keynote001.txt · Last modified: 2025/02/01 17:00 by 127.0.0.1
Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki